Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
about
Angiotensin receptor blockers for chronic heart failure and acute myocardial infarctionNew competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.Losartan: a selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure.
P2860
Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Angiotensin II receptor antago ...... in the elderly (ELITE) trial.
@en
type
label
Angiotensin II receptor antago ...... in the elderly (ELITE) trial.
@en
prefLabel
Angiotensin II receptor antago ...... in the elderly (ELITE) trial.
@en
P2093
P356
P1476
Angiotensin II receptor antago ...... in the elderly (ELITE) trial.
@en
P2093
P2860
P304
P356
10.1007/BF00878552
P577
1995-10-01T00:00:00Z